SAN DIEGO, April 26, 2023 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Robbins LLP investigates EQRx, Inc. EQRX to determine whether certain officers and directors
In the ongoing Phase 3 GEMSTONE-301 study, sugemalimab administered after treatment with either concomitant or sequential chemoradiation therapy demonstrated a statistically significant improvement in progression-free
Recovery after a serious car accident often takes weeks to months, while severe injuries may require a year or longer. The first 72 hours usually
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents